TCL Archive Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says. December 9, 2005
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions April 27, 2012
